Trump administration finalizes Medicare Advantage payment rate


Administrator for the Centers for Medicare & Medicaid Services Mehmet Oz speaks during an event sponsored by the Action for Progress Coalition, at the National Press Club in Washington, D.C., U.S., Feb. 2, 2026.

Al Drago | Reuters

The Trump administration on Monday finalized a 2027 payment rate increase to privately run Medicare plans that was far bigger than initially proposed, a boost to health insurer stocks.

The government will increase average Medicare Advantage payments by 2.48%, or more than $13 billion, in 2027, according to a release from the Centers for Medicare & Medicaid Services. The Trump administration in January proposed a payment rate hike of 0.09%, which pummeled shares of insurers that run those plans.

Shares of UnitedHealth and CVS Health rose more than 9% in after-hours trading on Monday. Meanwhile, Humana‘s stock jumped around 12%.

“Medicare Advantage and Part D should work for the people who rely on them,” said CMS Administrator Dr. Mehmet Oz in a release. “These updates keep coverage affordable and ensure patients get real value from their plans.” 

The closely watched government payment rate determines how much insurers can charge for monthly premiums and plan benefits they offer and, ultimately, their profits.

Medicare Advantage is a privately run health insurance plan contracted by Medicare. More than half of Medicare beneficiaries are enrolled in such plans, enticed by lower monthly premiums and extra benefits not covered by traditional Medicare, according to health policy research firm KFF.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.



View Original Source Here

You May Also Like
Tapestry (TPR) Q4 2025 earnings

Tapestry (TPR) Q4 2025 earnings

People walk past a Coach store on Madison Avenue in New York.…

Cramer’s lightning round: Realty Income is a buy

Loading chart… Energy Transfer LP: “I thought I’d never say this, but…
Ken Griffin’s flagship hedge fund at Citadel climbs 15.1% in 2024

Ken Griffin’s flagship hedge fund at Citadel climbs 15.1% in 2024

Ken Griffin, founder and CEO of Citadel, speaks during The New York…

Wegovy helps reduce heart failure symptoms in obese people, study says

In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT A selection…